Compare LBRDA & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LBRDA | MMED |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.5B |
| IPO Year | 2014 | 2025 |
| Metric | LBRDA | MMED |
|---|---|---|
| Price | $35.00 | $19.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $22.56 |
| AVG Volume (30 Days) | 183.8K | ★ 1.1M |
| Earning Date | 05-07-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.91 | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | $22,256,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | N/A | $15.99 |
| Revenue Next Year | $109.28 | $10.00 |
| P/E Ratio | $7.46 | ★ N/A |
| Revenue Growth | ★ 70.00 | 14.25 |
| 52 Week Low | $26.14 | $10.65 |
| 52 Week High | $65.40 | $20.88 |
| Indicator | LBRDA | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 63.46 |
| Support Level | $29.39 | $10.68 |
| Resistance Level | $37.32 | N/A |
| Average True Range (ATR) | 1.48 | 0.84 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 72.28 | 63.66 |
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.